The study, published Nov. 17 by Proceedings of the National Academy of Sciences, shows that triclosan causes liver fibrosis and
cancer in laboratory mice through molecular mechanisms that are also relevant in humans.
(It's relatively easy to cure
cancer in laboratory mice — «If you can't cure cancer in a mouse,» a cancer researcher once said to me, «then you should change careers» — but certainly not easy in people.
Not exact matches
Laboratory mice that have received rapamycin have reduced the age - dependent decline
in spontaneous activity, demonstrated more fitness, improved cognition and cardiovascular health, had less
cancer and lived substantially longer than
mice fed a normal diet.
Now,
in a new study using
laboratory - grown cells and
mice, Johns Hopkins scientists report that a method they used to track metabolic pathways heavily favored by
cancer cells provides scientific evidence for combining anti-
cancer drugs, including one
in a nanoparticle format developed at Johns Hopkins, that specifically target those pathways.
«Despite the low infection levels of
mouse cells with oHSV, we were able to cause a delay
in tumor growth
in one of the
cancer models and even cure many of the mice in a second model,» said first author Jennifer Leddon, who conducted much of the laboratory work during a research experience in the Center for Childhood Cancer and Blood Dis
cancer models and even cure many of the
mice in a second model,» said first author Jennifer Leddon, who conducted much of the
laboratory work during a research experience
in the Center for Childhood
Cancer and Blood Dis
Cancer and Blood Diseases.
Apart from a few studies
in mouse models and
in cell lines, there is no
laboratory evidence that synthetic phosphoethanolamine works as a
cancer drug.
In his current position at The Jackson
Laboratory, he has overall responsibility for the ongoing operational development of the PDX resource, which generates, banks, and distributes patient - derived xenograft (PDX)
mouse models of human
cancers.
The
laboratory of Marcos Malumbres, who is head of the Spanish National
Cancer Research Centre's (CNIO) Cell Division &
Cancer Group, working alongside Isabel Fariñas» team from the University of Valencia, shows,
in a study published today
in the journal Nature Communications, how
in mice the elimination of the Cdh1 protein — a sub-unit of the APC / C complex, involved
in the control of cell division — prevents cellular proliferation of rapidly dividing cells.
In both
laboratory dishes and
mice with human prostate
cancers, the nanoparticles proved extremely effective.
In their research, scientists at Rutgers created animal models that closely resemble the cancerous tumors found in women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory mic
In their research, scientists at Rutgers created animal models that closely resemble the cancerous tumors found
in women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory mic
in women with ovarian
cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory
cancer by injecting tumor tissues obtained from gynecological
cancer patients treated at the Cancer Institute into laboratory
cancer patients treated at the
Cancer Institute into laboratory
Cancer Institute into
laboratory mice.
Researchers
in the Cedars - Sinai Samuel Oschin Comprehensive
Cancer Institute eradicated solid tumors
in laboratory mice using a novel combination of two targeted agents.
Working with
mouse prostate
cancer cell lines
in the
laboratory, the investigators found that cells containing overexpressed TOP2A and EZH2 genes were highly sensitive to attack with a combination of two drugs.
He said experiments are under way to test the two - drug combination
in laboratory models of metastasis - prone prostate
cancer, leading eventually to tests
in mouse models.
But while most PDX
mice are used as general models of human
cancer in the
laboratory, others seek to use them as Fiebig originally hoped — as avatars to guide customized patient care.
Finally, Dr. Goldenring's
laboratory is also investigating the role of Rab25 as a tumor suppressor
in the colon using the Rab25 - / -; Smad3 + / -
mouse model, which develops spontaneous invasive distal colon
cancers.
These days,
mice grafted with human tumors, known as patient - derived xenograft (PDX)
mice, are common
in cancer research
laboratories.
In 2012 she joined the
laboratory of Dr. D.L. Konotyiannis at BSRC AL.Fleming, Greece as postdoctoral scientist, where she worked on the study of the RNA Binding Protein HuR during intestinal and lung inflammation and
cancer, using inducible, KO and Tg
mouse models and xenografts.
Largaespada's
laboratory is working to exploit insertional mutagenesis for
cancer gene discovery and functional genomics
in the
mouse.
«
Mouse models of human
cancer have taught us a great deal about the basic principles of
cancer biology,» says Inder Verma, Ph.D., a professor
in the
Laboratory of Genetics.
In the laboratory of Dr. Mintz, an eminent developmental geneticist, Dr. Jaenisch learned the embryological techniques that would lead to the development of the first transgenic mice carrying foreign sequences in all tissues — an approach that has proved to be critically important to understanding cancer, neurological and connective tissue diseases, and developmental abnormalitie
In the
laboratory of Dr. Mintz, an eminent developmental geneticist, Dr. Jaenisch learned the embryological techniques that would lead to the development of the first transgenic
mice carrying foreign sequences
in all tissues — an approach that has proved to be critically important to understanding cancer, neurological and connective tissue diseases, and developmental abnormalitie
in all tissues — an approach that has proved to be critically important to understanding
cancer, neurological and connective tissue diseases, and developmental abnormalities.
RNA from prostate
cancer tissues corresponding to the 39 individuals identified
in the prospective study was initially extracted
in a separate
mouse - free, XMRV PCR amplicon - free
laboratory (University of California, San Francisco).
With rudimentary
laboratories, one could argue that more was accomplished with regards to the effect of diet on
cancer in the former half of the century, as revolutionary researchers like Tannenbaum, Rous, and their colleagues provided us with dozens of animal studies linking diet and
cancer by exposing
mice to free radical - laden vegetable oils.32, 33 Several decades later, two other researchers, Dayton and Pearce, provided one of the few studies revealing what happens when we give humans vegetable oils and their accompanying free radicals when they randomized men to a corn oil solution and a similar rise
in cancer followed.34 It is no surprise that corn oil is often used
in animal studies to cause
cancer, as the ingestion of damaging free radicals predictably hastens
cancer development.35 Furthermore, these scientists were the first to show that fasting, restricting calories, and cutting carbohydrates could lower the chance of
cancer in animals exposed to dangerous chemicals and carcinogens.
Among it's valuable components are gamma - linolenic acid (GLA), linoleic and arachidonic acids, vitamin B12 (needed, especially for vegetarians, for healthy red blood cells), iron, a high level of protein (60 to 70 percent), essential amino acids, the nucleic acids RNA and DNA, chlorophyll, and phycocyanin, a blue pigment that is found only
in blue - green algae and that has increased the survival rate of
mice with liver
cancer in laboratory experiments.